Friday, February 11, 2022

Medication Guide - 2/11/2022

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Xyrem Sodium Oxybate SOLUTION;ORAL 021196 JAZZ PHARMS 02/09/2022
Xywav Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate SOLUTION;ORAL 212690 JAZZ 02/09/2022
Celexa Citalopram Hydrobromide TABLET;ORAL 020822 ALLERGAN 02/04/2022
Enjaymo Sutimlimab-Jome INJECTABLE;INJECTION 761164 BIOVERATIV THERAPEUTICS INC 02/04/2022
Keytruda Pembrolizumab SOLUTION;INTRAVENOUS 125514 MERCK SHARP DOHME 02/04/2022
Qudexy XR Topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122 UPSHER SMITH LABS 02/04/2022
Tafinlar Dabrafenib Mesylate CAPSULE;ORAL 202806 NOVARTIS 02/04/2022
Truxima Rituximab-Abbs INJECTABLE;INJECTION 761088 CELLTRION INC 02/04/2022
Valtoco Diazepam SPRAY;NASAL 211635 NEURELIS INC 02/04/2022

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment